Spotlight on Immuno-Oncology Conference 2023
01
Aug
-
02
Aug
2023
When
Seattle
USA
Where

Step into the cutting-edge world of Immuno-Oncology and elevate your understanding beyond the fundamentals of cell therapy and CAR T at the highly anticipated "Spotlight on Immuno-Oncology Conference 2023." This groundbreaking event promises to be a haven for oncology professionals, researchers, and enthusiasts seeking to explore the latest advancements in cancer immunotherapy.

The conference boasts an exceptional lineup of distinguished speakers who will delve into revolutionary topics that transcend traditional approaches. Learn about groundbreaking CAR designs and novel strategies that extend beyond B-Cell malignancies, opening up new possibilities for targeting various cancer types. Discover how genome and epigenome editing are reshaping the landscape of immuno-oncology, providing innovative tools to engineer immune cells with precision and efficacy.

One of the most captivating highlights of the conference is the exploration of direct in vivo delivery for cancer immunotherapy. Unravel the potential of in vivo approaches to administer therapies, bypassing certain limitations of ex vivo manipulation and bringing gene and cell therapy closer together.

The event will offer a unique opportunity to dig deeper into gene engineering and the seamless integration of gene and cell therapy, propelling the field of immuno-oncology into uncharted territories. As cutting-edge research and innovative breakthroughs unfold before your eyes, be prepared to witness the future of cancer treatment take shape.

Don't miss out on this invaluable occasion to connect with leading minds in the field, exchange ideas, and immerse yourself in the latest advancements at the forefront of immuno-oncology. Register today to secure your spot at the "Spotlight on Immuno-Oncology Conference 2023" and embark on a journey of scientific discovery that could revolutionize cancer therapeutics as we know it.

Similar Events

You May Like

Event

American Society of Gene & Cell Therapy

4.5/5
(2)

The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals.

01 - 02 Aug 2023
Hybrid

Grant HolleyPosted 1 year ago

Director of Science and Education

American Society of Gene & Cell Therapy

5/5
Review Title

Incredibly valuable professionally and the programming was absolutely the best.

Howell MoffettPosted 1 year ago

Associate Director

Outpace Bio

4.5/5
Review Title

Overall, it was a great experience. I felt that it was very well organized.

Speakers and Delegates
Industry Experts and Thought Leaders

Associate Professor of Microbiology and Immunology
Associate Professor of Microbiology, Immunology & Molecular Genetics
Senior Vice President Clinical Development
Chief Therapeutics Officer
Professor of Pathology and Laboratory Medicine
Chief Executive Officer
Assistant Professor
Sr. Scientist
Tenure Track W1 Professor for Translational Medicine
Associate Member and Attending Physician
Postdoctoral Fellow
Co-Founder
Chief Technology Officer
Chief Executive Officer
Chief Executive Officer
Assistant Professor in Pediatrics
Assistant Professor
Associate Director
Senior Principal Scientist

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Regeneron

Get in the Ideas Business. At Regeneron we believe that when the right idea finds the right team, powerful change is possible.

MeiraGTx

MeiraGTx is a gene therapy company with end-to-end capabilities in gene therapy discovery, development and GMP manufacturing. The company currently has 6 clinical programs, including one in a pivotal study.

Interius Biotherapeutics

Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.

Sana Biotechnology, Inc.

Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building dif

Organizer

Get emails from us

Thank you
Oops! Something went wrong